<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02307344</url>
  </required_header>
  <id_info>
    <org_study_id>0002-14-HYMC</org_study_id>
    <nct_id>NCT02307344</nct_id>
  </id_info>
  <brief_title>Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis</brief_title>
  <acronym>NASH NAFLD</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that Nigella Sativa will have an effect on Nonalcoholic
      Steatohepatitis and Liver Steatosis by enhancing lipophagy in the liver tissue.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Nigella Sativa on Liver Triglyceride Concentration</measure>
    <time_frame>One year</time_frame>
    <description>The difference in change in the average liver triglyceride concentration will be measured by MRI Spectroscopy between the Nigella Sativa arm and the placebo arm, at start and end of the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of Nigella Sativa on Improvement in NASH Activity Index</measure>
    <time_frame>One year</time_frame>
    <description>Improvement in Nash activity Index will be measured by the NAFLD Activity Score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of Nigella Sativa on Fibrosis Staging</measure>
    <time_frame>One year</time_frame>
    <description>Microscopic examination of two liver biopsies at start and end of the study, to determine fibrosis staging.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Nonalcoholic Steatohepatitis</condition>
  <condition>Liver Steatosis</condition>
  <arm_group>
    <arm_group_label>Nigella Sativa Supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fifty patients suffering from Nonalcoholic Steatohepatitis or Liver Steatosis will ingest capsules containing 2 grams of Nigella Sativa divided into 1 grams twice a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients receiving a placebo tablet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Twenty patients suffering from Nonalcoholic Steatohepatitis or Liver Steatosis will ingest placebo capsules twice a day, that look like the capsules of those receiving the Nigella Sativa.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nigella Sativa</intervention_name>
    <arm_group_label>Nigella Sativa Supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Capsules that contain a placebo but look like the Nigella Sativa capsules</description>
    <arm_group_label>Patients receiving a placebo tablet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suffering from Steatohepatitis

          -  Patients suffering from Liver Steatosis

        Exclusion Criteria:

          -  Patients suffering from viral hepatitis

          -  Patients with HIV infection

          -  Patients suffering from Wilsons Disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Saif Abu Mouch, MD</last_name>
    <phone>972-506-246-966</phone>
    <email>saif@hy.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Saif Abu Mouch, MD</last_name>
      <phone>972-50-624-6966</phone>
      <email>saif@hy.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Saif Abu Mouch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>December 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <last_update_submitted>December 1, 2014</last_update_submitted>
  <last_update_submitted_qc>December 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

